NAD Press Releases

NAD Recommends Cebria Discontinue Challenged Claims for Dietary Supplement Promoted as a Memory Protection Aid; Company to Appeal

NAD has recommended that Cebria, the maker of Cebria dietary supplement, discontinue certain claims challenged by the Council for Responsible Nutrition, including broad and unqualified memory improvement claims.

Read More

NAD Finds GSK Can Support Certain Claims for Citrucel, Recommends Company Modify, Discontinue Certain Claims After P&G Successfully Petitions NAD to Re-Open 1994 Case

NAD has determined that GSK Consumer Health can support certain claims for its Citrucel laxative product, but recommended that the company modify or discontinue certain claims, re-opening a matter heard by NAD in 1994.

Read More

NAD Refers Advertising for ‘Fungi-Nail’ Products to FTC for Further Review After Company Declines to Comply with NAD Recommendations

NAD has referred advertising claims made by Kramer Laboratories, Inc. to the FTC and Food and the FDA for further review after the company said it would not comply with NAD’s recommendation to change the name The Original Fungi-Nail Toe & Foot Brand product.

Read More

NAD Recommends Dr. Harold Katz Discontinue Health-Performance Claims for Therabreath Rinse, Lozenges; Company to Appeal

NAD has recommended Dr. Harold Katz, LLC, discontinue certain advertising claims for the company’s Therabreath Dry Mouth Treatment products, including claims that the products “relieve” or “fight” dry mouth symptoms. The company said it will appeal NAD’s adverse findings to NARB.

Read More

NAD Recommends SCA Personal Care Discontinue ‘Zero Leaks’ Claims for TENA Overnight Adult Underwear Following Challenge by Kimberly-Clark

NAD has recommended that SCA Personal Care, Inc., discontinue claims that consumers will experience “zero leaks” when wearing the company’s TENA Overnight adult incontinence underwear. The claims were challenged by Kimberly-Clark Corporation, the maker of competing incontinence products.

Read More

NAD Recommends Alcon Laboratories Discontinue Certain Claims for ‘Clear Care’ Products, Including Certain ‘Natural Tears’ Claims

NAD has recommended Alcon Laboratories, Inc. discontinue claims that because they are preservative-free, the company’s Clear Care and Clear Care Plus contact lens solutions are “more like natural tears.” The claims were challenged by Bausch & Lomb, a competing maker of products for contact-lens patients.

Read More